These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 35801303

  • 1. Directional atherectomy and drug-coated balloon angioplasty vs. bare nitinol stent angioplasty for femoropopliteal artery lesions.
    Wei L, Guo J, Guo L, Qi L, Cui S, Tong Z, Hou P, Gu Y.
    Vasa; 2022 Sep; 51(5):275-281. PubMed ID: 35801303
    [Abstract] [Full Text] [Related]

  • 2. Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans.
    Cai Z, Guo L, Qi L, Cui S, Tong Z, Guo J, Wang Z, Gu Y.
    Ann Vasc Surg; 2020 Apr; 64():181-187. PubMed ID: 31449956
    [Abstract] [Full Text] [Related]

  • 3. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K, Schwindt A, Torsello G, Stachmann A, Hericks C, Bosiers MJ, Beropoulis E, Stahlhoff S, Bisdas T.
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O, Oztas DM, Meric M, Beyaz MO, Ulukan MO, Yildiz CE, Unal O, Ugurlucan M.
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [Abstract] [Full Text] [Related]

  • 5. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials.
    Zhou Y, Wang J, He H, Li Q, Li M, Li X, Shu C.
    Int J Cardiol; 2021 Nov 15; 343():122-130. PubMed ID: 34461162
    [Abstract] [Full Text] [Related]

  • 6. Mid-term Efficacy and Safety of Drug-coated Balloon versus Nitinol Bare Metal Stent for Primary Lesions in Femoropopliteal Artery Disease.
    Ma H, Zhang X, Li J, Li Q, Li W, Jiao Y, Jiang J, He C, He Z, Li W, Zhang T, Zhang X.
    Ann Vasc Surg; 2022 Apr 15; 81():316-323. PubMed ID: 34762999
    [Abstract] [Full Text] [Related]

  • 7. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K, Schwindt A, Torsello G, Beropoulis E, Stachmann A, Hericks C, Bollenberg L, Bisdas T.
    J Endovasc Ther; 2018 Feb 15; 25(1):92-99. PubMed ID: 29251204
    [Abstract] [Full Text] [Related]

  • 8. Drug-Coated Balloon versus Bare Nitinol Stent in Femoropopliteal Artery: 12 Months Outcome from a Single Center in China.
    Zhao H, Ma B, Chen J, Zheng L, Sun CR, Sun MS, Zhang JB, Fan XQ, Liu P, Ye ZD.
    Ann Vasc Surg; 2021 Jul 15; 74():367-381. PubMed ID: 33556529
    [Abstract] [Full Text] [Related]

  • 9. Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
    Rocha-Singh KJ, Sachar R, DeRubertis BG, Nolte-Ernsting CCA, Winscott JG, Krishnan P, Scott EC, Garcia LA, Baeriswyl JL, Ansel G, Rosenfield K, Zeller T, REALITY Investigators.
    Catheter Cardiovasc Interv; 2021 Sep 15; 98(3):549-558. PubMed ID: 34080792
    [Abstract] [Full Text] [Related]

  • 10. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
    Zeller T, Langhoff R, Rocha-Singh KJ, Jaff MR, Blessing E, Amann-Vesti B, Krzanowski M, Peeters P, Scheinert D, Torsello G, Sixt S, Tepe G, DEFINITIVE AR Investigators.
    Circ Cardiovasc Interv; 2017 Sep 15; 10(9):e004848. PubMed ID: 28916599
    [Abstract] [Full Text] [Related]

  • 11. Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion.
    Yang L, Quan J, Dong J, Ding N, Han Y, Cong L, Lin Y, Liu J.
    Sci Rep; 2024 Jan 02; 14(1):63. PubMed ID: 38167567
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of Stented vs Nonstented Femoropopliteal Lesions Treated With Drug-Coated Balloon Angioplasty.
    Giannopoulos S, Strobel A, Rudofker E, Kovach C, Kokkosis AA, Armstrong EJ.
    J Endovasc Ther; 2023 Apr 02; 30(2):194-203. PubMed ID: 35179065
    [Abstract] [Full Text] [Related]

  • 13. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG, Behan S, Jawaid O, Hossain P, Giannopoulos S, Singh GD, Laird JR, Valle JA, Waldo SW, Armstrong EJ.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):439-446. PubMed ID: 31816169
    [Abstract] [Full Text] [Related]

  • 14. One-Year Clinical Outcome and Risk Factor Analysis of Directional Atherectomy Followed With Drug-Coated Balloon for Femoropopliteal Artery Disease.
    Feng Z, Yang S, Sang H, Xue G, Ni Q, Zhang L, Zhang W, Fang X, Ye M.
    J Endovasc Ther; 2021 Dec 15; 28(6):927-937. PubMed ID: 34251279
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM, Hyder ON, Soukas PA.
    Cardiovasc Revasc Med; 2019 Mar 15; 20(3):210-214. PubMed ID: 29970328
    [Abstract] [Full Text] [Related]

  • 16. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ.
    Cardiovasc Revasc Med; 2020 Jun 15; 21(6):771-778. PubMed ID: 31761634
    [Abstract] [Full Text] [Related]

  • 17. Rotational atherectomy with adjunctive balloon angioplasty in calcified chronic total occlusions of superficial femoral artery.
    Engin AY, Saydam O.
    Vascular; 2021 Oct 15; 29(5):682-692. PubMed ID: 33167805
    [Abstract] [Full Text] [Related]

  • 18. Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.
    Armstrong EJ, Jeon-Slaughter H, Kahlon RS, Niazi KA, Shammas NW, Banerjee S.
    J Endovasc Ther; 2020 Feb 15; 27(1):60-65. PubMed ID: 31686573
    [Abstract] [Full Text] [Related]

  • 19. Early outcomes of novel Temren atherectomy device combined with drug-coated balloon angioplasty for treatment of femoropopliteal lesions.
    Yiğit G.
    Vascular; 2022 Aug 15; 30(4):739-748. PubMed ID: 34180304
    [Abstract] [Full Text] [Related]

  • 20. Primary Drug-Coated Balloon Versus Drug-Eluting Stent for Native Atherosclerotic Femoropopliteal Lesions: A Systematic Review and Meta-Analysis.
    Zenunaj G, Traina L, Acciarri P, Mario Cosacco A, Alesiani F, Baldazzi G, Gasbarro V.
    Ann Vasc Surg; 2023 May 15; 92():294-303. PubMed ID: 36746268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.